Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D002415:Cats; D004088:Dihydroergotoxine / Q000378:metabolism / Q000494:pharmacology; D004569:Electroencephalography; D004873:Ergolines / Q000378:metabolism; D004877:Ergoloid Mesylates / Q000378:metabolism / Q000494:pharmacology*; D002546:Ischemic Attack, Transient / Q000378:metabolism; D010477:Perfusion; D012769:Shock
D004873:Ergolines; D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates; D015105:3',5'-Cyclic-AMP Phosphodiesterases